BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 525286)

  • 21. [Effects of pilocarpine in new ophthalmic formulations on intraocular pressure in rabbits with ocular hypertension].
    Xu Y; Chen Z; Song J
    Zhonghua Yan Ke Za Zhi; 2002 Dec; 38(12):721-4. PubMed ID: 12654220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Phytantriol-Based Lyotropic Liquid Crystalline Gel for Efficient Ophthalmic Delivery of Pilocarpine Nitrate.
    Wang X; Zhang Y; Huang J; Tian C; Xia M; Liu L; Li Z; Cao J; Gui S; Chu X
    AAPS PharmSciTech; 2019 Jan; 20(1):32. PubMed ID: 30603986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary pharmacokinetic model of pilocarpine uptake and distribution in the eye.
    Himmelstein KJ; Guvenir I; Patton TF
    J Pharm Sci; 1978 May; 67(5):603-6. PubMed ID: 641790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modified beta-cyclodextrin (SBE7-beta-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits.
    Jarho P; Järvinen K; Urtti A; Stella VJ; Järvinen T
    J Pharm Pharmacol; 1996 Mar; 48(3):263-9. PubMed ID: 8737051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of aqueous and oily pilocarpine in the production of ocular hypotension.
    Bhojwani SC; Jones DK
    Br J Ophthalmol; 1981 Aug; 65(8):530-2. PubMed ID: 7295614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ocular penetration of topical Delta9-tetrahydrocannabinol from rabbit corneal or cul-de-sac application site.
    Green KE; Kearse CE
    Curr Eye Res; 2000 Jul; 21(1):566-70. PubMed ID: 11035538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of topically applied pilocarpine in the albino rabbit eye.
    Makoid MC; Robinson JR
    J Pharm Sci; 1979 Apr; 68(4):435-43. PubMed ID: 438963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of acute closed-angle glaucoma with miotics and timolol.
    Airaksinen PJ; Saari KM; Tiainen TJ; Jaanio EA
    Br J Ophthalmol; 1979 Dec; 63(12):822-5. PubMed ID: 526463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of permeability coefficients of ophthalmic drugs through different layers of porcine, rabbit and bovine eyes.
    Loch C; Zakelj S; Kristl A; Nagel S; Guthoff R; Weitschies W; Seidlitz A
    Eur J Pharm Sci; 2012 Aug; 47(1):131-8. PubMed ID: 22659372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanistic studies on transcorneal permeation of pilocarpine.
    Sieg JW; Robinson JR
    J Pharm Sci; 1976 Dec; 65(12):1816-22. PubMed ID: 1032669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical characterization and clinical evaluation of tacrolimus eye drops.
    Luaces-Rodríguez A; Touriño-Peralba R; Alonso-Rodríguez I; García-Otero X; González-Barcia M; Rodríguez-Ares MT; Martínez-Pérez L; Aguiar P; Gómez-Lado N; Silva-Rodríguez J; Herranz M; Ruibal-Morell Á; Lamas MJ; Otero-Espinar FJ; Fernández-Ferreiro A
    Eur J Pharm Sci; 2018 Jul; 120():152-161. PubMed ID: 29705214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged pulse-entry of pilocarpine with a soluble drug insert.
    Salminen L; Urtti A; Kujari H; Juslin M
    Graefes Arch Clin Exp Ophthalmol; 1983; 221(2):96-9. PubMed ID: 6654048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular penetration of topically applied mannitol.
    Lazar M; Nowakowski J; Furman M; Shore B
    Am J Ophthalmol; 1970 Nov; 70(5):849-51. PubMed ID: 5477174
    [No Abstract]   [Full Text] [Related]  

  • 34. Vehicle effects in ophthalmic bioavailability: an evaluation of polymeric inserts containing pilocarpine.
    Saettone MF; Giannaccini B; Chetoni P; Galli G; Chiellini E
    J Pharm Pharmacol; 1984 Apr; 36(4):229-34. PubMed ID: 6144768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular delivery of pilocarpine from erodible matrices.
    Grass GM; Cobby J; Makoid MC
    J Pharm Sci; 1984 May; 73(5):618-21. PubMed ID: 6737234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The intraocular dynamics of vancomycin hydrochloride ophthalmic ointment (TN-011) in rabbits.
    Fukuda M; Hanazome I; Sasaki K
    J Infect Chemother; 2003 Mar; 9(1):93-6. PubMed ID: 12673416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular pharmacokinetics comparison between 0.2% olopatadine and 0.77% olopatadine hydrochloride ophthalmic solutions administered to male New Zealand white rabbits.
    Iyer GR; Cason MM; Womble SW; Li G; Chastain JE
    J Ocul Pharmacol Ther; 2015 May; 31(4):204-10. PubMed ID: 25775192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
    Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
    Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular penetration of pilocarpine: the effect on concentration on the ocular penetration of pilocarpine.
    Ramer RM; Gasset AR
    Ann Ophthalmol; 1974 Nov; 6(11):1160-2. PubMed ID: 4429321
    [No Abstract]   [Full Text] [Related]  

  • 40. [Interactions between macromolecular adjuvants and drugs. Part 19: In vitro and in vivo testing of polyvinyl alcohol and other macromolecular adjuvants as vehicles for eyedrops (author's transl)].
    Keipert S; Voigt R; Karst R; Nowak R
    Pharmazie; 1979 Dec; 34(12):818-24. PubMed ID: 545352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.